- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00605436
Yoga for the Treatment of Metabolic Syndrome
January 30, 2008 updated by: University of California, San Francisco
Restorative Yoga for Therapy of the Metabolic Syndrome: A Pilot Trial
We tested the following hypotheses:
- That a standardized yoga therapy will improve insulin sensitivity (primary outcome), and other features of the metabolic syndrome such as hypertension and dyslipidemia (secondary outcomes), we will perform a 2-hour oral glucose tolerance test, fasting blood tests, and a physical examination before and after randomization of subjects to a 10-week yoga therapy intervention or wait-list control group.
- That a yoga therapy is feasible in overweight and underactive individuals with the metabolic syndrome, that adherence to a yoga intervention is acceptable, and that yoga therapy is associated with improved quality of life, we will assess the adherence to twice-weekly yoga group sessions (for weeks1-5) and weekly yoga group sessions (for weeks 6-10), frequency of home yoga therapy practice, and self-reported quality of life before and after the intervention in both treatment groups.
- To elucidate a potential mechanism for the effect of yoga on changes in insulin resistance by evaluating markers of inflammation from adipose tissue (adipocytokines). We hypothesize that these biochemical parameters will show modest improvement with yoga therapy and that changes in these parameters will be associated with improvements in insulin sensitivity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Study Interventions: There will be a 12-week intervention period.
- Yoga Therapy Group: Those randomized to yoga therapy will receive twice-weekly group yoga sessions at the Osher Center for the entire intervention period. The yoga postures and breathing techniques will be taught by a qualified and certified yoga instructor using a standardized protocol that was determined by a Yoga Expert Panel. Each group yoga session will take approximately 90 minutes. Participants will also be required to practice yoga at home at least 3 times per week, and be given yoga materials (mat, blocks, straps), an instruction manual, and a video for their use at home. They will be asked to keep a calendar log of the dates/times that they practiced yoga at home. This group will also receive a 20-30 minute session with a counselor to discuss Standard Health Education at the beginning of the 12-week intervention. This session will be similar to the control group intervention.
- Standard Health Education Group: Participants assigned to the standard health education group will receive an individual 20-30 minute session with a trained research associate within a week of their baseline visit. In this session, participants will be informed of the importance of a healthy lifestyle, given written information of the Food Guide Pyramid12 and told to follow the equivalent of the National Cholesterol Education Program Step I diet13. They will be counseled to reduce weight and increase physical activity. This is similar to the intervention given to the "Standard Lifestyle Group" in the Diabetes Prevention Program4.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94115
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- to be between the ages of 30 and 65 years,
fulfill at least three criteria for the metabolic syndrome per the NCEP guidelines:
- waist circumference (>88 cm for women; >102 cm for men),
- HDL-cholesterol (<50 mg/dl for women; <40 mg/dl for men),
- triglycerides >=150 mg/dL
- fasting glucose >=100 mg/dL, and/or
- high blood pressure (>=130/>=85 or use of antihypertensive medication), and
- report an underactive or sedentary lifestyle defined as accumulating less than 30 minutes of moderate intensity endurance exercise 5 days per week.
Exclusion Criteria:
- Pregnancy or lactation
- Coronary heart disease (defined as a myocardial infarction or cardiac intervention with percutaneous transluminal catheterization or coronary artery bypass graft surgery) event or hospitalization in the past 6 months
- Chronic illnesses: cancer, kidney disease, cirrhosis, rheumatogic diseases, or chronic infections
- Current use of these medications: oral diabetes medications, insulin, steroid hormones, oral contraceptives, hormone replacement therapy, niacin, fibrates.
- Regular participation (>1/week) yoga for past 3 months or concurrent use of yoga
- Current major psychiatric illness, cognitive impairment, or substance abuse
- Plans to move out of the study region within 6 months
- Life-expectancy of < 6 months
- Concurrent enrollment in any other studies, experimental therapies, or blinded treatments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A
Restorative yoga therapy group: one orientation workshop for 3 hours, then twice-weekly group yoga therapy classes for first 5 weeks followed by once-weekly group yoga classes for another 5 weeks.
The group will also be asked to practice their yoga postures at home for 30 minutes three times per week.
|
3-hour workshop at study initiation.
Then twice-weekly group yoga classes for 5 weeks, then once-weekly group yoga classes for 5 weeks.
Home yoga practice for 90 minutes/week throughout the 10 week trial.
|
|
No Intervention: B
The control group is a wait-list control group with no active intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fasting plasma glucose level
Time Frame: 10 weeks
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood pressure
Time Frame: 10 weeks
|
10 weeks
|
|
Feasability of yoga postures
Time Frame: 10 weeks
|
10 weeks
|
|
Adherence to protocol
Time Frame: 10 weeks
|
10 weeks
|
|
Insulin sensitivity
Time Frame: 10 weeks
|
10 weeks
|
|
Weight
Time Frame: 10 weeks
|
10 weeks
|
|
Waist circumference
Time Frame: 10 weeks
|
10 weeks
|
|
Heart rate variability
Time Frame: 10 weeks
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Alka M. Kanaya, MD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Primary Completion (Actual)
April 1, 2007
Study Completion (Actual)
June 1, 2007
Study Registration Dates
First Submitted
January 16, 2008
First Submitted That Met QC Criteria
January 30, 2008
First Posted (Estimate)
January 31, 2008
Study Record Updates
Last Update Posted (Estimate)
January 31, 2008
Last Update Submitted That Met QC Criteria
January 30, 2008
Last Verified
January 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H9377-29543-02
- CHR#H9377-29543-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.